Archive for July 8, 2020

E-Alternative Solutions Receives Acceptance and Filing Letters from U.S. FDA for Premarket Tobacco Product Applications for Leap® and Leap Go® Vapor Products
By eas_admin
July 8, 2020
Corporate

E-Alternative Solutions Receives Acceptance and Filing Letters from U.S. FDA for Premarket Tobacco Product Applications for Leap® and Leap Go® Vapor Products

EAS submissions move to Substantive Review phase E-Alternative Solutions (EAS), an independent, family-owned innovator of consumer-centric brands, announced today that the U.S. Food and Drug Administration (FDA) has issued Acceptance and Filing Letters for its…
READ MORE

Recent Posts

Recent Comments

    Archives

    Categories

    Latest Posts

    Jacopo D’Alessandris of E-Alternative Solutions: 5 Ways To Create a Wow! Customer Experience

    December 15, 2020

    E-Alternative Solutions Launches “The Smart Choice” Campaign Offering Loyalty Rewards to Consumers on its Full Suite of Leap® and Leap Go® Vapor Products

    December 3, 2020

    Purilum and EAS Enter into Exclusive E-liquid Supply Agreement

    November 9, 2020

    Search Keywords